NCT02658175 - The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 23, 2015

Primary Completion Date

January 15, 2020

Study Completion Date

January 15, 2020

Conditions

Familial Chylomicronemia SyndromeLipoprotein Lipase DeficiencyHyperlipoproteinemia Type 1

Interventions

DRUG

Volanesorsen

300 mg volanesorsen administered via SC injection.

Trial Locations (34)

7925

IONIS Investigative Site, Cape Town

13110

IONIS Investigative Site, Safed

13353

IONIS Investigative Site, Berlin

13385

IONIS Investigative Site, Marseille

15001

IONIS Investigative Site, A Coruña

19104

IONIS Investigative Site, Philadelphia

23510

IONIS Investigative Site, Norfolk

28007

IONIS Investigative Site, Madrid

33434

IONIS Investigative Site, Boca Raton

41013

IONIS Investigative Site, Seville

44800

IONIS Investigative Site, Nantes

50009

IONIS Investigative Site, Zaragoza

50937

IONIS Investigative Site, Cologne

75013

IONIS Investigative Site, Paris

77030

IONIS Investigative Site, Houston

90127

IONIS Investigative Site, Palermo

94143

IONIS Investigative Site, Huntington Beach

IONIS Investigative Site, San Francisco

98104

IONIS Investigative Site, Seattle

02114

IONIS Investigative Site, Boston

04040-001

IONIS Investigative Site, São Paulo

CEP-05403-000

IONIS Investigative Site, São Paulo

V6Z1Y6

IONIS Investigative Site, Vancouver

G7H 7K9

IONIS Investigative Site, Chicoutimi

H2W 1R7

IONIS Investigative Site, Montreal

G1V 4W2

IONIS Investigative Site, Québec

00161

IONIS Investigative Site, Roma

IONIS Investigative Site, Rome

1105 AZ

IONIS Investigative Site, Amsterdam-Zuidoost

08036

IONIS Investigative Site, Barcelona

B9 5SS

IONIS Investigative Site, Birmingham

SE1 7EH

IONIS Investigative Site, London

M13 9WL

IONIS Investigative Site, Manchester

M23 9LT

IONIS Investigative Site, Manchester